Want to see GB:AMS full AI Analyst Report?
Advanced Medical Solutions (AMS) Ratios
Advanced Medical Solutions Ratios
GB:AMS's free cash flow for Q2 2026 was $-3.01M. For the 2026 fiscal year, GB:AMS's free cash flow was decreased by $-7.42M and operating cash flow was $4.42M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.79 | 2.85 | 5.67 | 5.82 | 6.76 |
| Quick Ratio | 1.39 | 1.60 | 4.00 | 4.59 | 5.63 |
| Cash Ratio | 0.36 | 0.38 | 2.79 | 3.63 | 4.29 |
| Solvency Ratio | 0.23 | 0.16 | 0.59 | 0.66 | 0.71 |
| Operating Cash Flow Ratio | 0.58 | 0.38 | 0.57 | 1.19 | 1.79 |
| Short-Term Operating Cash Flow Coverage | 2.53 | 1.97 | 10.61 | 25.57 | -33.90 |
| Net Current Asset Value | $ 4.70M | $ -21.20M | $ 77.35M | $ 87.44M | $ 78.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.23 | 0.03 | 0.03 | 0.04 |
| Debt-to-Equity Ratio | 0.32 | 0.37 | 0.04 | 0.04 | 0.05 |
| Debt-to-Capital Ratio | 0.24 | 0.27 | 0.04 | 0.04 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.22 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.53 | 1.62 | 1.18 | 1.19 | 1.17 |
| Debt Service Coverage Ratio | 2.17 | 2.24 | 16.88 | 17.35 | 134.56 |
| Interest Coverage Ratio | 4.32 | 2.94 | 49.17 | 39.01 | 20.95 |
| Debt to Market Cap | 0.15 | 0.18 | 0.00 | 0.00 | -0.00 |
| Interest Debt Per Share | 0.40 | 0.43 | 0.04 | 0.05 | 0.05 |
| Net Debt to EBITDA | 1.46 | 2.45 | -1.63 | -2.08 | -2.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.51% | 46.62% | 55.57% | 55.19% | 51.67% |
| EBIT Margin | 9.61% | 7.54% | 16.33% | 20.97% | 20.90% |
| EBITDA Margin | 18.95% | 16.72% | 24.88% | 28.10% | 29.05% |
| Operating Profit Margin | 9.61% | 5.89% | 14.96% | 20.02% | 21.18% |
| Pretax Profit Margin | 7.77% | 5.53% | 16.76% | 20.84% | 20.24% |
| Net Profit Margin | 4.35% | 4.00% | 12.59% | 16.41% | 16.10% |
| Continuous Operations Profit Margin | 4.41% | 4.02% | 12.59% | 16.41% | 16.10% |
| Net Income Per EBT | 55.97% | 72.22% | 75.10% | 78.76% | 79.52% |
| EBT Per EBIT | 80.86% | 93.96% | 112.05% | 104.10% | 95.59% |
| Return on Assets (ROA) | 2.52% | 1.82% | 5.49% | 7.26% | 7.01% |
| Return on Equity (ROE) | 3.85% | 2.95% | 6.51% | 8.62% | 8.22% |
| Return on Capital Employed (ROCE) | 6.38% | 3.03% | 7.06% | 9.63% | 9.89% |
| Return on Invested Capital (ROIC) | 3.47% | 2.13% | 5.25% | 7.52% | 7.86% |
| Return on Tangible Assets | 5.26% | 4.06% | 10.39% | 22.42% | 22.85% |
| Earnings Yield | 2.12% | 1.67% | 3.54% | 3.64% | 2.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.57 | 3.31 | 5.66 | 5.77 | 5.17 |
| Payables Turnover | 9.06 | 2.51 | 9.00 | 8.68 | 10.76 |
| Inventory Turnover | 1.72 | 1.54 | 1.56 | 2.00 | 2.72 |
| Fixed Asset Turnover | 4.70 | 3.87 | 4.26 | 4.29 | 3.96 |
| Asset Turnover | 0.58 | 0.46 | 0.44 | 0.44 | 0.44 |
| Working Capital Turnover Ratio | 2.67 | 1.94 | 1.20 | 1.20 | 1.20 |
| Cash Conversion Cycle | 252.35 | 202.71 | 258.58 | 204.11 | 170.93 |
| Days of Sales Outstanding | 79.86 | 110.38 | 64.47 | 63.27 | 70.63 |
| Days of Inventory Outstanding | 212.78 | 237.56 | 234.65 | 182.87 | 134.22 |
| Days of Payables Outstanding | 40.29 | 145.23 | 40.54 | 42.04 | 33.92 |
| Operating Cycle | 292.64 | 347.94 | 299.12 | 246.14 | 204.85 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.13 | 0.08 | 0.06 | 0.13 | 0.14 |
| Free Cash Flow Per Share | 0.10 | 0.06 | 0.01 | 0.08 | 0.11 |
| Dividend Paid and CapEx Coverage Ratio | 2.19 | 1.81 | 0.84 | 1.89 | 2.95 |
| Capital Expenditure Coverage Ratio | 3.91 | 4.12 | 1.25 | 2.72 | 4.71 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.19 | 1.35 | 2.78 | 3.08 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.09 | 0.10 | 0.22 | 0.28 |
| Free Cash Flow Yield | 4.55% | 2.99% | 0.56% | 3.05% | 3.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 47.19 | 59.70 | 28.26 | 27.48 | 41.70 |
| Price-to-Sales (P/S) Ratio | 2.05 | 2.39 | 3.56 | 4.51 | 6.71 |
| Price-to-Book (P/B) Ratio | 1.82 | 1.76 | 1.84 | 2.37 | 3.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.97 | 33.42 | 179.91 | 32.76 | 30.44 |
| Price-to-Operating Cash Flow Ratio | 16.34 | 25.32 | 36.38 | 20.71 | 23.97 |
| Price-to-Earnings Growth (PEG) Ratio | 1.19 | -1.08 | -1.29 | 1.69 | 0.40 |
| Enterprise Value Multiple | 12.29 | 16.72 | 12.68 | 13.97 | 21.11 |
| Enterprise Value | 533.39M | 496.15M | 398.04M | 488.25M | 665.88M |
| EV to EBITDA | 12.29 | 16.72 | 12.68 | 13.97 | 21.11 |
| EV to Sales | 2.33 | 2.79 | 3.15 | 3.93 | 6.13 |
| EV to Free Cash Flow | 24.94 | 39.15 | 159.47 | 28.53 | 27.81 |
| EV to Operating Cash Flow | 18.55 | 29.66 | 32.24 | 18.03 | 21.90 |
| Tangible Book Value Per Share | 0.25 | 0.13 | 0.50 | 0.21 | 0.18 |
| Shareholders’ Equity Per Share | 1.20 | 1.12 | 1.13 | 1.09 | 0.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.43 | 0.27 | 0.25 | 0.21 | 0.20 |
| Revenue Per Share | 1.06 | 0.83 | 0.58 | 0.57 | 0.50 |
| Net Income Per Share | 0.05 | 0.03 | 0.07 | 0.09 | 0.08 |
| Tax Burden | 0.56 | 0.72 | 0.75 | 0.79 | 0.80 |
| Interest Burden | 0.81 | 0.73 | 1.03 | 0.99 | 0.97 |
| Research & Development to Revenue | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 |
| SG&A to Revenue | 0.41 | 0.38 | 0.40 | 0.38 | 0.34 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 2.89 | 2.36 | 0.78 | 1.33 | 1.74 |
Currency in GBP
